PLAN ONE: MEDICATION + SUPPORT PLAN TWO: PRESCRIPTION + SUPPORT Regardless of your path, if youre interested in GLP-1 weight loss or need a new GLP-1 partner, WE CAN HELP
Retatrutide: Eli Lillys Triple-Agonist Weight Loss Injection Explained (May 2026 Update) Eli Lillys latest development, Retatrutide , is showing extraordinary potential as a groundbreaking treatment for obesity and metabolic health
Researchers who study the pancreatic peptide hormone system will recognize glucagon as the metabolic counterweight to insulin, and harnessing it pharmacologically opens therapeutic possibilities that the research community has pursued for decades
GLP-1 receptor agonists, originally developed for type 2 diabetes management, had become blockbuster weight loss drugs
Additionally, IL-1beta is thought to be involved in amyloid precursor synthesis and the production of other cytokines involved with neurodegenerative disorders [58]
The results appear March 4 in The BMJ